Why GLP-1 Drugs Cause Constipation & How to Manage It

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Constipation affects 20–30% of patients taking GLP-1 medications like semaglutide and tirzepatide during the first month of treatment. This gastrointestinal side effect occurs because GLP-1 drugs work by slowing how fast food moves through your digestive system—the same action that reduces appetite and promotes weight loss.

How GLP-1 Medications Affect Your Digestive System

GLP-1 receptor agonists bind to nerve endings in your stomach and intestines, triggering signals that tell your brain you feel full faster and longer. This delayed gastric emptying is the primary mechanism behind appetite suppression—but it also means food moves more slowly through your entire digestive tract. Your colon receives stool more gradually, and less water is reabsorbed, sometimes leading to harder, less frequent bowel movements.

The effect intensifies during dose escalation, when patients move from lower to higher amounts of medication over several weeks. Your body gradually adapts to this slowed transit time, which is why constipation often improves after 4–6 weeks of consistent use. Semaglutide injection patients at PlexusDx typically experience the strongest initial effect during the first two weeks of therapy.

Why Constipation Happens More Often at the Start of Treatment

Your gut contains trillions of bacteria that help regulate bowel movements and water absorption. When GLP-1 medications suddenly slow stomach emptying, your microbiome receives food at a different rate and rhythm, disrupting its normal rhythm. This shift causes temporary constipation until your intestinal bacteria and transit time reach a new equilibrium, usually within 4–8 weeks.

Additionally, many patients reduce their total caloric intake significantly when starting GLP-1 therapy—sometimes consuming 30–50% fewer calories than before. Less food volume means less digestive content moving through your system, which naturally produces fewer, firmer stools. Combined with the slowed transit effect of the medication itself, this creates a powerful recipe for constipation during the initial treatment phase.

Evidence-Based Strategies to Prevent and Relieve GLP-1 Constipation

Hydration is your first line of defense: drinking 80–100 ounces of water daily helps soften stool and supports normal bowel function despite slower transit. Fiber intake also matters—aim for 25–30 grams per day from whole grains, vegetables, and fruits. However, increase fiber gradually (5 grams per week) to avoid bloating, since GLP-1 medications already slow digestion. Soluble fiber sources like oatmeal and beans are gentler than insoluble fiber when starting treatment.

Movement and exercise stimulate intestinal contractions that propel stool forward, so 20–30 minutes of daily activity (walking, swimming, cycling) can significantly improve regularity. Over-the-counter stool softeners containing docusate or osmotic laxatives like polyethylene glycol (Miralax) are safe first-line options. Prune juice and magnesium supplements (200–400 mg daily) offer natural alternatives, though always consult your provider before adding supplements, especially if you have kidney concerns.

When Constipation Signals You Need Medical Guidance

Mild constipation (fewer than three stools per week) is expected and manageable in most GLP-1 patients. However, severe abdominal pain, bloating lasting more than one week, or no bowel movement for five or more days warrants contacting your PlexusDx provider immediately. These symptoms could indicate bowel obstruction or other serious conditions requiring prompt evaluation.

PlexusDx patients taking semaglutide injection starting at $149/month can discuss constipation management during their ongoing provider check-ins, which are included as part of personalized treatment plans. Your provider may adjust your dose timing, suggest specific dietary changes, or recommend a temporary laxative protocol. If constipation persists beyond six weeks despite lifestyle modifications, switching to oral semaglutide or exploring the Precision Peptide Genetic Test to identify peptide-pathway predispositions may help optimize your therapy.

The Role of Genetic Variation in GLP-1 Side Effect Sensitivity

Not all patients experience the same degree of constipation on GLP-1 medications—genetic differences in how your body processes these drugs play a significant role. Variants in the GLP1R gene (rs6923761) and MC4R gene (rs17782313) influence how sensitively your digestive system responds to dose changes and medication timing. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 49 peptides to reveal your individual risk profile for constipation and other GLP-1 side effects.

Understanding your genetic predispositions allows your PlexusDx provider to anticipate constipation risk and proactively recommend prevention strategies tailored to your biology. Some patients with specific FTO or GIPR variants may benefit from more gradual dose escalation or combination approaches (like GLP-Squared, which pairs semaglutide and tirzepatide) to minimize digestive disruption. This precision approach transforms constipation management from a one-size-fits-all protocol into a personalized strategy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is constipation a sign that my GLP-1 medication isn't working?

No. Constipation and appetite suppression are caused by the same mechanism—slowed stomach emptying. If you're constipated, your medication is likely working as intended. Mild constipation usually resolves within 4–6 weeks as your body adapts, while appetite suppression typically persists and strengthens, supporting your weight loss goals.

What do clinical trials say about GLP-1 constipation rates?

Phase 3 trials of semaglutide (the medication in PlexusDx's injection option) reported constipation in 16–22% of patients at higher doses, compared to 9% on placebo. Tirzepatide trials showed slightly higher rates (22–28%) due to its dual GLP-1/GIP action. Most cases were mild to moderate and improved within 4–8 weeks of continued treatment.

How much does PlexusDx semaglutide cost, and does it include constipation support?

Compounded semaglutide injection starts at $149/month flat—your dose may need to go up, but your price won't. PlexusDx includes provider consultations where you can discuss constipation strategies, lifestyle modifications, and dietary recommendations. HSA/FSA funds are accepted, and no insurance or membership fees apply across all 50 states.

Could constipation signal a serious problem like bowel obstruction?

While rare, persistent severe abdominal pain, complete loss of bowel function for 5+ days, or acute bloating can indicate obstruction or other complications requiring medical attention. Contact your provider immediately if you experience these warning signs.

Can the Precision Peptide Genetic Test predict whether I'll get constipation?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes variants in GLP1R, MC4R, FTO, and GIPR genes, mapping 150+ genetic insights across 14 pathways to reveal your individual risk profile for constipation and other GLP-1 side effects. This data helps your provider personalize your treatment and prevention strategy from the start.

Why Do GLP-1 Medications Cause Constipation?